Ironwood Pharmaceuticals

^{, Nasdaq: IRWD}

Developing a new treatment for irritable bowel syndrome and constipation.

Industry: Health Care

First Day Return: +3.6%

IRWD

Developing a new treatment for irritable bowel syndrome and constipation.

IPO News for Ironwood Pharmaceuticals

Ironwood Pharma quiet period ends March 14 03/09/10
One out of four IPOs prices this week, others postpone 02/05/10
Ironwood Pharmaceuticals prices IPO at $11.25, below the range 02/03/10

IPO Data
IPO Date	02/02/2010
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$188
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.ironwoodpharma.com
Headquarters	Cambridge, MA, United States
Founded	1998
Employees at IPO	165

IPO News for Ironwood Pharmaceuticals

Ironwood Pharma quiet period ends March 14 03/09/10
One out of four IPOs prices this week, others postpone 02/05/10
Ironwood Pharmaceuticals prices IPO at $11.25, below the range 02/03/10

Ironwood Pharmaceuticals (IRWD) Performance